AKT1 and ovarian carcinoma: Similarly, our GSEA analysis also demonstrated a positive correlation between PDGFRα expression and PI3K-AKT signaling pathway activity in ovarian cancer, gastric cancer, and bladder cancer (Fig. 6B–D).